JP2022542075A5 - - Google Patents

Info

Publication number
JP2022542075A5
JP2022542075A5 JP2022504265A JP2022504265A JP2022542075A5 JP 2022542075 A5 JP2022542075 A5 JP 2022542075A5 JP 2022504265 A JP2022504265 A JP 2022504265A JP 2022504265 A JP2022504265 A JP 2022504265A JP 2022542075 A5 JP2022542075 A5 JP 2022542075A5
Authority
JP
Japan
Prior art keywords
xyl
rha
fuc
saponin
saponin derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022504265A
Other languages
English (en)
Japanese (ja)
Other versions
JP7807366B2 (ja
JP2022542075A (ja
Filing date
Publication date
Priority claimed from PCT/EP2019/084292 external-priority patent/WO2020126627A1/en
Application filed filed Critical
Priority claimed from PCT/EP2020/071045 external-priority patent/WO2021014019A1/en
Publication of JP2022542075A publication Critical patent/JP2022542075A/ja
Publication of JP2022542075A5 publication Critical patent/JP2022542075A5/ja
Priority to JP2026004618A priority Critical patent/JP2026065112A/ja
Application granted granted Critical
Publication of JP7807366B2 publication Critical patent/JP7807366B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022504265A 2019-07-25 2020-07-24 改良された治療濃度域をもつサポニン誘導体 Active JP7807366B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026004618A JP2026065112A (ja) 2019-07-25 2026-01-14 改良された治療濃度域をもつサポニン誘導体

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
NL2023568 2019-07-25
NL2023568 2019-07-25
EPPCT/EP2019/084210 2019-12-09
PCT/EP2019/084292 WO2020126627A1 (en) 2018-12-21 2019-12-09 Improved cell-targeting binding molecule
PCT/EP2019/084210 WO2020126609A2 (en) 2018-12-21 2019-12-09 Drug conjugate
PCT/EP2019/084290 WO2020126626A1 (en) 2018-12-21 2019-12-09 Biologically active cluster of molecules
EPPCT/EP2019/084290 2019-12-09
EPPCT/EP2019/084292 2019-12-09
NL2025904 2020-06-24
NL2025904 2020-06-24
PCT/EP2020/071045 WO2021014019A1 (en) 2019-07-25 2020-07-24 Saponin derivatives with improved therapeutic window

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026004618A Division JP2026065112A (ja) 2019-07-25 2026-01-14 改良された治療濃度域をもつサポニン誘導体

Publications (3)

Publication Number Publication Date
JP2022542075A JP2022542075A (ja) 2022-09-29
JP2022542075A5 true JP2022542075A5 (cg-RX-API-DMAC10.html) 2023-08-01
JP7807366B2 JP7807366B2 (ja) 2026-01-27

Family

ID=74193344

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022504265A Active JP7807366B2 (ja) 2019-07-25 2020-07-24 改良された治療濃度域をもつサポニン誘導体
JP2026004618A Pending JP2026065112A (ja) 2019-07-25 2026-01-14 改良された治療濃度域をもつサポニン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026004618A Pending JP2026065112A (ja) 2019-07-25 2026-01-14 改良された治療濃度域をもつサポニン誘導体

Country Status (14)

Country Link
US (1) US20230357310A1 (cg-RX-API-DMAC10.html)
EP (2) EP4635501A3 (cg-RX-API-DMAC10.html)
JP (2) JP7807366B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220038744A (cg-RX-API-DMAC10.html)
CN (2) CN114222750B (cg-RX-API-DMAC10.html)
AU (2) AU2020316679B2 (cg-RX-API-DMAC10.html)
BR (1) BR112022001389A8 (cg-RX-API-DMAC10.html)
CA (1) CA3146481A1 (cg-RX-API-DMAC10.html)
DK (1) DK4003427T3 (cg-RX-API-DMAC10.html)
ES (1) ES3056941T3 (cg-RX-API-DMAC10.html)
IL (2) IL316853A (cg-RX-API-DMAC10.html)
MX (1) MX2022001066A (cg-RX-API-DMAC10.html)
PT (1) PT4003427T (cg-RX-API-DMAC10.html)
WO (1) WO2021014019A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220023433A1 (en) 2018-12-21 2022-01-27 Sapreme Technologies B.V. Saponin Conjugates
CN111198236A (zh) * 2020-01-14 2020-05-26 山东中医药大学 利用高效液相色谱和液质联用色谱鉴别金银花和山银花的方法
KR20230043113A (ko) * 2020-06-24 2023-03-30 사프렘 테크놀로지스 비.브이. 의약용 사포닌 유도체
WO2021261995A1 (en) * 2020-06-24 2021-12-30 Sapreme Technologies B.V. Combination of an antibody-drug conjugate and an antibody-saponin conjugate
EP4117730A1 (en) * 2020-06-24 2023-01-18 Sapreme Technologies B.V. Conjugate of saponin and single-domain antibody, pharmaceutical composition comprising said conjugate, therapeutic use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583112A (en) * 1987-05-29 1996-12-10 Cambridge Biotech Corporation Saponin-antigen conjugates and the use thereof
CA2522213A1 (en) * 2003-04-08 2004-10-28 Dante J. Marciani Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines
WO2015184451A1 (en) * 2014-05-30 2015-12-03 Memorial Sloan-Kettering Cancer Center Minimal saponin analogues, synthesis and use thereof
AU2016423814B2 (en) * 2016-09-26 2023-11-23 Desert King Chile S.A. Production of biomass in ultra high density plantations
EP3652190B1 (en) * 2017-07-11 2023-06-14 Freie Universität Berlin Novel uses of a saponin and method for its isolation
US20220023433A1 (en) * 2018-12-21 2022-01-27 Sapreme Technologies B.V. Saponin Conjugates

Similar Documents

Publication Publication Date Title
JP2023532681A5 (cg-RX-API-DMAC10.html)
US9107962B2 (en) Anthracycline-antibody conjugates for cancer therapy
AU2025203092A9 (en) Saponin conjugates
EP1594548B1 (en) Anthracycline-anti-cd74 antibody conjugates
JP2023532040A5 (cg-RX-API-DMAC10.html)
EP2900678B1 (en) Multimeric mannosides, a process for preparing the same and their uses as a drug
JPH01246295A (ja) 新規なリンカーを有するアントラサイクリン・イムノコンジュゲート及びその製造方法
AU2020295308B2 (en) Agents for cleaving labels from biomolecules in vivo
EP4003427B1 (en) Saponin derivatives with improved therapeutic window
US20230365617A1 (en) Saponin derivatives for use in medicine
EP3292131B1 (en) Improved preparation of vaccines against streptococcus pneumoniae type 3
JP2023532679A5 (cg-RX-API-DMAC10.html)
JP2001500901A (ja) 抗腫瘍および駆虫剤を溶解するために特に利用されるチオウレイド―シクロデキストリン、およびその製造方法
JP3795588B2 (ja) 動的流動系においてe−セレクチンに依存する細胞回転および付着を惹起する新規な炭水化物リガンド類(ミエロローリン)
JP2023542500A5 (cg-RX-API-DMAC10.html)
JPH06510746A (ja) 免疫抑制性および寛容原性修飾ルイスxおよびルイスa化合物
JP2023533693A5 (cg-RX-API-DMAC10.html)
RU2022104765A (ru) Производные сапонина с улучшенным терапевтическим окном
TW202545566A (zh) 雙醣連接子及其製備方法和用途
HK40074297B (en) Saponin derivatives with improved therapeutic window
EP3231810A1 (en) Improved preparation of vaccines against streptococcus pneumoniae type 3
JPH01180828A (ja) 自己免疫疾患治療剤
Fulton Cyclodextrin-based cluster compounds
Kim et al. 3.3 Further Anomeric Esters
HK1233519A1 (en) Calicheamicin derivative-carrier conjugates